Researchers will need to explore other strategies to see if the mechanisms observed in cells and mice can ever translate into meaningful cognitive benefits.
Int J Clin Pharmacol Res 10:355360 Bersani G, Meco G, Denaro A, Liberati D, Colletti C, Nicolai R, Bersani FS, Koverech A (2013) L-acetylcarnitine in dysthymic disorder in elderly patients: a double-blind, multicenter, controlled randomized study vs
In clinical trials, the 12 mg dose produced 24.2% body weight loss at 48 weeks (Phase 2) and 28.7% at 68 weeks (Phase 3 TRIUMPH-4)
It may aid GLP-1 function somewhat, but effects are indirect and not comparable to GLP-1 receptor agonists
TB-500 is a synthetic peptide fragment of thymosin beta-4 that promotes actin regulation and cellular motility, particularly in sites of trauma